Malmö June 27, 2019 Acarix CADScor®System included in NICE guidelines (UK) Acarix AB (publ) (ACARIX: FN Stockholm) today announced that the CADScor®System has been included as a first line investigation for ruling out suspected stable Coronary Artery Disease by the British National Institute for Health and Care Excellence (NICE). The CADScor®System was included in the […]